Deciphera To Present At Oppenheimer Annual Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced that Michael D. Taylor, Ph.D., Deciphera’s President and Chief Executive Officer will present a corporate update at the Oppenheimer 26th Annual Healthcare Conference on Tuesday, December 8, 2015 at 4:30 p.m. ET in New York.